20203 ⎘
Medicinal preparations containing organic active ingredients Ethers or acetals
Sub-classes:ANTICANCER DRUG AND ANTICANCER DRUG SCREENING METHOD
#2NOVEL CANNABINOID DERIVATIVES
#3COMPOSITIONS, REAGENTS, AND METHODS FOR TREATING PITT-HOPKINS SYNDROME
#4GLIOMA THERAPY
#5RESCORCINOLS, METHODS FOR THEIR MANUFACTURE, AND USES THEREOF
#6USE OF COMPOSITION OF ALCOHOL AND COOLING AGENT IN REGULATING SEXUAL FUNCTIONS, PROTECTING CARDIOVASCULAR AND CEREBROVASCULAR SYSTEMS, PROMOTING REGENERATION OF LIVER CELLS, PREVENTING AND/OR TREATING TUMORS, AND IMPROVING IMMUNITY AND SLEEP QUALITY
#7Topical Hyperpigmentation Compositions and Method of Use
#8COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF AS INHIBITORS OF RAN GTPase
#9EMULSIONS OF BIOACTIVE LIPOPHILIC COMPOUNDS INCLUDING OILS
#10TOPICAL PHARMACEUTICAL FORMULATIONS CONTAINING A LOW CONCENTRATION OF BENZOYL PEROXIDE IN SUSPENSION IN WATER AND A WATER-MISCIBLE ORGANIC SOLVENT
#11Method for removing keratotic plugs
#12TREATMENT OF OBESITY AND RELATED CONDITIONS
#13PHARMACEUTICAL FORMULATIONS FOR A LIQUID DOSAGE FORM AND A CONTROLLED RELEASE DOSAGE FORM
#14COMPOSITIONS AND METHODS FOR INHIBITING BLOOD CANCER CELL GROWTH
#15COMBINATION THERAPIES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DISORDERS
#16Treatment for dry eyes
#17NOVEL FORMULATIONS AND METHODS FOR TREATING DERMATOLOGICAL DISORDERS OR DISEASES
#18DOSING REGIMENS FOR TREATING METAL-MEDIATED CONDITIONS
#19MULTI-PARTICULATE PHARMACEUTICAL COMPOSITION, IMMEDIATE RELEASE PELLETS, SUSTAINED RELEASE PELLETS, ENTERIC RELEASE PELLETS AND USE THEREOF
#20Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide
#21Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
#22COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF AS INHIBITORS OF RAN GTPASE
#23Combination therapies for the treatment of alzheimer's disease and related disorders
#24METHODS FOR THE TREATMENT OF ERECTILE DYSFUNCTION USING FISPEMIFENE
#25COMPOSITION AND METHOD FOR TREATING SKIN CONDITIONS
#26Cancer therapy
#27Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
#28Oral compositions and methods of use
#29Methods and dose packs for monitoring medication adherence
#30Cancer therapy
#31FOOD BASED DELIVERY OF THERAPEUTIC AGENT FOR TREATMENT OF HEPATIC ENCEPHALOPATHY
#32Method for treating an autoimmune neurological disease and/or neurodegenerative disease and pharmaceutical formulations for a liquid dosage form and a controlled release dosage form
#33Composition for treating neuropathy, process and method of treatment thereof
#34Pharmaceutical composition for preventing or treating autoimmune diseases comprising cedrol or derivatives thereof, or pharmaceutically acceptable salts thereof
#35Cosmetic composition for preventing or ameliorating hypersensitive skin comprising cedrol or derivatives thereof, or pharmaceutically acceptable salts thereof
#36Method for the treatment or prevention of lower urinary tract symptoms
#37Formulations and methods for treating dermatological disorders and diseases
#38Combination therapies for the treatment of Alzheimer's disease and related disorders
#39Combination therapies for the treatment of Alzheimer's disease and related disorders
#40Combination therapies for the treatment of Alzheimer'S disease and related disorders
#41LIDAR based 3-D imaging with far-field illumination overlap
#42Composition and method for treating skin conditions
#43METHODS AND APPARATUS FOR REDUCING ANXIETY IN A PATIENT
#44ENHANCED DELIVERY EPINEPHRINE COMPOSITIONS
#45DOSING REGIMENS FOR TREATING METAL-MEDIATED CONDITIONS
#46Composition and method for treating skin conditions
#47Methods and dose packs for monitoring medication adherence
#48Aerosol composition for the prevention of symptoms of metal induced allergy and a method of synthesizing the same
#49Cooling adjunct for medications to treat disorders in the nasal cavity
#50Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
#51Honey bee mite disruptive compounds and methods of application
#52Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
#53PREDICTING AND REDUCING COGNITIVE DECLINE BASED ON GSK-3 LEVELS
#54Methods for treating occular irritation involving tearing by administering modulators of TRPM8
#55Method for producing a flurane complex
#56Method for treating vaginal dryness by administering transient receptor potential cation channel subfamily M member 8 (TRPM8) receptor agonists
#57Agent for inhibiting odor of pyrazine derivatives
#58Castration-resistant prostate cancer
#59Compounds for the treatment of diabetes and disease complications arising from same
#60Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
#61Combination Therapies for the Treatment of Alzheimer's Disease and Related Disorders
#62Use of edelfosine and other synthetic ether alkyl-lysophospholipids (APLs) for seizures and related diseases
#63Combination therapies for the treatment of Alzheimer's disease and related disorders
#64Combination therapies for the treatment of alzheimer's disease and related disorders
#65Method for enhancing the bioavailability of ospemifene
#66Composition for treating neuropathy, a process and a method of treatment thereof
#67Anxiolytic effect of pterostilbene
#68Composition and methods for treating skin conditions
#69Inhibitors of the tumor necrosis factor receptor complex
#70Method for the treatment or prevention of lower urinary tract symptoms
#71Use of TRMP8 for treating opthalmic diseases or conditions involving tearing
#72Combination therapies for the treatment of Alzheimer's disease and related disorders
#73Cosmetic or dermatological preparation for prophylaxis and/or treatment of atopic dermatitis
#74Compositions and methods for treating Alzheimer's disease and related disorders and promoting a healthy nervous system
#75Active substance combination of licochalcone A and phenoxyethanol
#76Method for the treatment or prevention of lower urinary tract symptoms
#77Sesquiterpenoid-based compounds, extracts of comprising the same, and use thereof
#78Anti-microbial hand towel with time-delay chromatic transfer indicator and absorbency rate delay
#79METHOD FOR PRODUCING A PLANT EXTRACT FROM DESMODIUM AND ITS EXTRACT THEREOF
#80TOPICAL COMPOSITION CONTAINING SILICONE BASE
#81Miliacin and sphingolipids and/or phospholipids composition for hair and scalp care
#82Method for enhancing the bioavailability of ospemifene
#83Formulations and methods for treating dermatological disorders or diseases
#84Method for the treatment of tuberculosis
#85Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
#86Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
#87O-(substituted benzyl) phosphoramidate compounds and therapeutic use
#88Process for oral care material taste and/or odor improvement
#89Derivatives of tetracaine
#90Volatile anesthetic compositions and methods of use
#91Amide gellant compositions containing isosorbide
#92Ophthalmic composition comprising ws-12 and methods to treat xerophthalmia
#93TRANSDERMAL COMPOSITIONS AND METHODS FOR TREATING STRETCH MARKS
#94Orally bioavailable stilbenoids-compositions and therapeutic applications thereof
#95AGENT FOR INHIBITING ODOR OF PYRAZINE DERIVATIVES
#96Compositions and methods for treating Alzheimer's disease and related disorders and promoting a healthy nervous system
#97TRANSDERMAL ABSORPTION PROMOTER, AND EXTERNAL SKIN FORMULATION THEREOF
#98Anti-microbial hand towel with time-delay chromatic transfer indicator and absorbency rate delay
#99Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with 7-hydroxystaurosporine
#100SPECIAL COMPOSITION FOR THE USE THEREOF AS A DRUG
#101PEGYLATED OPIOIDS WITH LOW POTENTIAL FOR ABUSE AND SIDE EFFECTS
#102Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
#103TREATMENT OF ISCHEMIC TISSUE
#104Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
#105Lysine Specific Demethylase-1 inhibitors and their use
#106Method for enhancing the bioavailability of ospemifene
#107Methods and Compounds Useful to Induce Apoptosis in Cancer Cells
#108T TYPE CALCIUM CHANNEL BLOCKERS AND THE TREATMENT OF DISEASES
#109BIOLOGICALLY ACTIVE FOOD ADDITIVE FOR THE PROPHYLAXIS OF OSTEOPOROSIS DISEASE
#110COMPOSITION AND METHOD FOR TREATING SKIN CONDITIONS
#111SURFACE COATINGS FOR SKIN
#112METHOD FOR TREATING OR AMELIORATING MUCOCUTANEOUS OR OCULAR TOXICITIES
#113AGENT AND METHOD FOR TREATING REFRACTORY CHRONIC HEPATITIS C
#114Methods compounds and pharmaceutical compositions for treating anxiety and mood disorders
#115Compounds, compositions and methods for reducing toxicity and treating or preventing diseases
#116AMIDE DERIVATIVES OF ETHACRYNIC ACID
#117FINELY PULVERIZED PHARMACEUTICAL COMPOSITION
#118GASTRIC ACID SECRETION INHIBITOR, AND POTASSIUM CHANNEL INHIBITOR
#119PROCESS FOR PREPARATION OF ROSUVASTATIN ACETONIDE CALCIUM
#120Antimicrobial compositions comprising trimethylene glycol oligomer and methods of using the compositions
#121Antimicrobial compositions
#122Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
#123COMPOSITION
#124Volatile Anesthetic Compositions and Methods of Use
#125KIT OF TAMPONING LIQUIDS AND A METHOD FOR THE TREATMENT OF TEARS AND/OR DETACHMENTS OF THE RETINA USING SUCH LIQUIDS
#126Novel Medicament Combinations for the Treatment of Respiratory Diseases
#127Methods and compounds useful to induce apoptosis in cancer cells
#128Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
#129Solubilized benzoyl small molecule
#130Compounds and method for coating surfaces in a hemocompatible manner
#131METHOD FOR THE TREATMENT OR PREVENTION OF LOWER URINARY TRACT SYMPTOMS
#132Method for the alleviation of dyspareunia in women
#133METHODS FOR THE TREATMENT OF ERECTILE DYSFUNCTION USING FISPEMIFENE
#134NOVEL LIPID COMPOUNDS
#135T Type Calcium Channel Blockers and the Treatment of Diseases
#136ANTIDIARRHETIC COMPOSITION, PRODUCT CONTAINING THE SAME AND METHOD OF PREVENTING DIAHHREA
#137METHODS OF TREATING ALZHEIMER'S DISEASE
#138Composition for prevention or treatment of bone metabolism disorder comprising D-pinitol as an active ingredient
#139Orally bioavailable stilbenoids—compositions and therapeutic applications thereof
#140Treatment of Wounds and Compositions Employed
#141AGENTS AND METHOD FOR INCREASING BRAIN CHAPERONIN LEVELS
#142STILBENE-BASED COMPOSITIONS AND METHODS OF USE THEREFOR
#143Inositol Compounds and Uses of Same in the Treatment of Diseases Characterized by Abnormal Protein Folding or Aggregation or Amyloid Formation, Desposition, Accumulation or Persistence
#144Use of (−)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of type 2 diabetes
#145ANTI-TUMOR COMPOSITION
#146Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
#147Adjuvant for Transdermal or Transmucosal Administration and Pharmaceutical Preparation Containing the Same
#148Methods of treating parkinson's disease using halogenated volatile compounds
#149MULTI-PHASE RELEASE POTASSIUM GUAIACOLSULFONATE COMPOSITIONS
#150Prophylactic or therapeutic agent for viral disease
#151Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
#152Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
#153Extended release formulations of guaifenesin
#154SCYLLO-INOSITOL DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASES CHARACTERIZED BY ABNORMAL PROTEIN FOLDING OR AGGREGATION OR AMYLOID FORMATION, DEPOSITION, ACCUMULATION OR PERSISTENCE
#155Anti-tumor composition
#156ACTIVE SUBSTANCE COMBINATION OF LICOCHALCONE A AND PHENOXYETHANOL
#157Functional polymer compositions
#158Use of and extracts thereof in preventing and decreasing toxic and side effects of antineoplastic drugs
#159Methods of treating ear infections
#160Anticancer composition comprising obovatol or obovatal
#161METHODS FOR THE TREATMENT OF ERECTILE DYSFUNCTION USING FISPEMIFENE
#162Utilization of rhinologically active substances
#163Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
#164REDUCTION OF REACTIVE OXYGEN SPECIES IN CHRONIC WOUND MANAGEMENT
#165Diterpene compounds having an atisane framework, compositions thereof, and methods of production
#166Sir2a-based therapeutic and prophylactic methods
#167Liquid dosage form of acetaminophen
#168Multi-Phase Release Potassium Guaiacolsulfonate Compositions
#169ANTIVIRAL COMPOSITIONS AND METHODS OF USE
#170Non-narcotic biphasic release compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction
#171TOPICAL COMPOSITIONS WITH LONG LASTING EFFECT
#172Phosphodiesterase inhibitors and nitric oxide donors, compositions and methods of use
#173Narcotic biphasic release compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction
#174Treatment of Wounds and Compositions Employed
#175USE OF (-)(3-TRIHALOMETHYLPHENOXY)(4-HALOPHENYL) ACETIC ACID DERIVATIVES FOR TREATMENT OF INSULIN RESISTANCE, TYPE 2 DIABETES AND HYPERLIPIDEMIA
#176Anti-microbial hand towel with time-delay chromatic transfer indicator and absorbency rate delay
#177Composition for preventing and/or treating bone disease, physiologically functional or health food containing thereof, and pharmaceutical containing thereof as active ingredients
#178USE OF CERTAIN PHENYL-NAPHTHYL COMPOUNDS THAT DO NOT HAVE SIGNIFICANT AFFINITY TO ER ALPHA OR ER BETA FOR PROTECTION OF NEURONS AND OLIGODENDROCYTES IN THE TREATMENT OF MULTIPLE SCLEROSIS
#179Partially-fluorinated ethers, compositions and uses thereof, for long-term tamponade in the eye
#180Composition and method for the therapeutic modulation of matrix metalloproteinase
#181Pharmaceutical composition containing obovatol as an active ingredient for the prevention and treatment of neurodegenerative diseases
#182Compositions for delivery of coenzyme Q10
#183Antimicrobial compositions for treating fabrics and surfaces
#184Use of aroma compounds as defoaming agents for ophthalmic solutions with high concentrations of surfactants
#185Octahydronaphthalene derivative and medicine
#186Reduction of reactive oxygen species in chronic wound management
#187Composition having liver function protecting effect
#188Inositol compounds and uses of same in the treatment of diseases characterized by abnormal protein folding or aggregation or amyloid formation, desposition, accumulation or persistence
#189Methods and compositions for inhibiting the proliferation of prostate cancer cells
#190Formulations of fispemifene
#191Oral formulations of ospemifene
#192Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
#193Use of pinitol or chiroinositol for protecting the liver
#194Synergistic mixtures of aromatic alcohols and derivatives thereof and tropolone (derivatives)
#195Anticancer composition comprising obovatol or obovatal
#196Use of an alkyl ether of hydroxystilbene for the treatment of dry skin
#197Treatment of wounds and compositions employed
#198Active substance combination of licochalcone A and phenoxyethanol
#199Systemic oxygenation via gastric perfusion with perfluorocarbon (PFC)
#200Preparation of sevoflurane with negligible water content
#201Composition and method for the therapeutic modulation of matrix metalloproteinase
#202Antiviral compositions and methods of use
#203Stable pharmaceutical composition of fluoroether compound for anesthetic use method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound
#204Methods for treating neoplastic, angiogenic, vascular, fibroblastic, and/or immunosuppressive irregularities of the eye and/or joint via administration of combretastatin based medicaments, and iontophoretic devices for delivering combretastatin based medicaments
#205Tubulin binding agents and corresponding prodrug constructs
#206Method of administering split doses of a vascular targeting agent
#207Compositions and methods for treating alzheimer's disease and related disorders and promoting a healthy nervous system
#208Phenolic antiseptic compositions and methods of use
#209Treatment of wounds and compositions employed
#210Anti-tumor composition
#211Methods for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women
#212Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
#213Method for reducing radiation-induced normal tissue damage
#214Non-halogenated phenyl substituted phenols, antimicrobial compositions containing the same, and methods of using the same
#21511-Beta hydroxysteroid dehydrogenase type 1 inhibitors as anti-obesity/anti-diabetes compounds and 17-beta hydrosteroid dehydrogenase type I inhibitors as useful agents for the treatment of cancers, especially breast cancer
#216Antimicrobial compositions
#217Methods for treating illnesses of the tracheo-bronchial tract, especially chronic obstructive pulmonary disease (COPD)
#218Encapsulation of chemical compounds in fluorous-core and fluorous-inner-shell micelles formed from semifluorinated-block or fluorinated-block copolymers
#219Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
#220Treating or preventing restless legs syndrome using prodrugs of GABA analogs
#221Method for treatment or prevention of osteoporosis in individuals with high bone turnover
#222Solid formulations of ospemifene
#223Method for enhancing the bioavailablity of ospemifene
#224Compounds and method for coating surfaces in a haemocompatibe manner
#225Antiaging composition
#226Novel substituted alkane compounds and uses thereof
#227Targeted oxidative therapeutic formulation
#228Targeted oxidative therapeutic formulation
#229Active substance combination of licochalcone a and phenoxyethanol
#230Method for treating aspects of alcoholism, addiction and psychosis
#231Antibacterial composition
#232Decongestant and expectorant tablets
#233Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, Type 2 diabetes and hyperlipidemia
#234Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
#235Methods and pharmaceutical compositions for modulating heparanase activation and uses thereof
#236Method for the treatment of arthritis and pain
#237Utilization of rhinologically active substances
#238Methods and compounds useful to induce apoptosis in cancer cells
#239Combination therapies for the treatment of Alzheimer's disease and related disorders
#240Method of treatment for periodontal pockets